The impact of DRD3, HS1-BP3, and LINGO1 gene mutations on the development and clinical heterogeneity of essential tremor in the Sakha Republic (Yakutia)

Introduction. The ETM1, ETM2 and ETM3 loci are linked with the development of essential tremor (ET). It has been established that a mutation in the LINGO1 gene is a significant risk factor for ET development. The aim of the study was to investigate the role of Ser9Gly polymorphism in the DRD3 gene,...

Full description

Bibliographic Details
Main Authors: Tatyana G. Govorova, Tatyana E. Popova, Alexey A. Tappakhov, Polina I. Golikova, Anastasya L. Danilova, Ulyana D. Antipina, Vera N. Samorseva, Alena Yu. Petrova, Michil E. Andreev, Nadezhda N. Lyasheeva
Format: Article in Journal/Newspaper
Language:English
Russian
Published: Research Center of Neurology 2020
Subjects:
Online Access:https://doi.org/10.25692/ACEN.2020.1.6
https://doaj.org/article/682a9ca14df543e69b4511765beee543
Description
Summary:Introduction. The ETM1, ETM2 and ETM3 loci are linked with the development of essential tremor (ET). It has been established that a mutation in the LINGO1 gene is a significant risk factor for ET development. The aim of the study was to investigate the role of Ser9Gly polymorphism in the DRD3 gene, the Ala265Gly mutation in the HS1-BP3 gene and rs9652490 polymorphism in the LINGO1 gene in the development and clinical heterogeneity of ET in the Sakha Republic population (Yakutia). Materials and methods. Thirty-nine patients with a confirmed diagnosis of ET and 48 patients with Parkinson disease were examined. The control group consisted of 87 healthy individuals. Polymorphism carrier status and gene mutations were identified using real-time polymerase chain reaction. Results. The Ser/Gly genotype with Ser9Gly polymorphism in the DRD3 gene and the A/A genotype with rs9652490 polymorphism in the LINGO1 gene increases the risk of developing ET by 2.35 (p = 0.02) and 2.42 (p = 0.04) times, respectively. Moreover, the A/A genotype of the rs9652490 in the LINGO1 gene increases the risk for ET-plus syndrome by 2.17 times (p = 0.02). Our data didnt confirm the role of the Ala265Gly mutation in the HS1-BP3 gene in development of the ET.